FDA Adverse Event
Injury
Summary report: N
GORE EXCLUDER AAA ENDOPROSTHESIS
MDR report key: 2202335
·
Received August 8, 2011
Report
- Report Number
- 2953161-2011-00174
- Event Type
- Injury
- Date Received
- August 8, 2011
- Date of Event
- August 2, 2011
- Report Date
- August 3, 2011
- Manufacturer
- W.L. GORE & ASSOCIATES
- Product Code
- MIH
- PMA / PMN Number
- P020004
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- OH, US
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
A REVIEW OF THE MFG PAPERWORK HAS BEEN CONDUCTED. THE REVIEW OF THE MFG PAPERWORK VERIFIED THAT THIS LOT MET ALL PRE-RELEASE SPECS.
Description of Event or Problem · 1
ON (B)(6) 2011, THE PT UNDERWENT REPAIR OF AN ABDOMINAL AORTIC ANEURYSM. AFTER A GORE EXCLUDER AAA ENDOPROSTHESIS FEATURING C3 WAS IMPLANTED, IT WAS THOUGHT THAT CANNULATION HAD BEEN OBTAINED; HOWEVER, THE CONTRALATERAL LEG COMPONENT WAS DEPLOYED OUTSIDE OF THE GATE. THE PT UNDERWENT AN AORTA UNI-ILIAC WITH AN ADD'L GORE EXCLUDER AAA ENDOPROSTHESIS FEATURING C3 AND A FEMORAL-FEMORAL BYPASS WITH A GORE PROPATEN VASCULAR GRAFT. THE PT TOLERATED THE PROCEDURE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | GORE EXCLUDER AAA ENDOPROSTHESIS | MIH/SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT | MIH | W.L. GORE & ASSOCIATES | WLG425 | 9085952 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 58 YR | Hospitalization| R | COUMADIN| GEMFIBROZIL| ISOSORBIDE| COREG| NITROGLYCERIN| PLAVIX| PROMETHAZINE| CLARITIN| RESTORIL| PROAIR| PACERONE| LOVAZA| ENALAPRIL |